Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07516899 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mass Balance Study of [14C] LPM3770164 in Healthy Participants

Name: Mass Balance Study of [14C] LPM3770164 in Healthy Participants — clinical trial record (NCT07516899)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorLuye Pharma Group Ltd.

Started2026-04-30

View on ClinicalTrials.gov ↗

Record status

This record was last updated April 8, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Luye Pharma Group Ltd.

16 trials monitored

See all monitored trials

Huntington's Disease

78 trials monitored

See 3 trials at risk

This is a phase 1, single-center, single-dose, open-label mass-balance study to evaluate radioactive recovery rate, radioactive PK characteristics, metabolite identification, and to observe the safety in healthy male subjects of \[14C\] LPM3770164.

Trial Details

NCT Number	NCT07516899
Lead Sponsor	Luye Pharma Group Ltd.
Conditions	Huntington Disease
Enrollment	8 participants
Start Date	2026-04-30
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-08